I wanted to write something different a proper, honest, nutritionists answer, grounded in both the clinical picture and my own experience of coaching PCOS and metabolic-health clients through exactly this combination
8.4 Clinical differentiation in a post-GLP-1 landscape The success of incretin-based therapies has raised expectations for efficacy in metabolic disease, particularly in obesity, where benchmarks for weight loss and cardiometabolic improvement are now well established (Kushner and Kahan, 2024)
Fabian reported progress on her study of the effects of 6-month treatment with tirzepatide on risk biomarkers for the development of breast cancer, including absolute fibroglandular volume (FGV), visceral fat, and others
Understanding your options and what to expect Delivery timing and how the process works General questions before you decide Taste Changes Some People Report While Taking GLP-1 Medicines Some people taking GLP-1 medications report changes in how food tastes or appeals to them
The agency has warned telehealth companies for marketing unapproved drugs such as retatrutide, including direct-to-consumer marketing, and has warned API distributors for selling retatrutide to compounders
9,43 Various underlying mechanisms of central and peripheral LR are known
